EPRX
Eupraxia Pharmaceuticals Inc.
$6.52
+0.18 (+2.84%)
At close · Jul 15
Market Cap
$402.41M
Shares
65,326,947
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$38.58M
-51.3%
FY2025
Diluted EPS
-$1.03
-35.5%
FY2025
Operating Cash Flow
-$28.55M
+4.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| $0 | $0 | $0 | — | |
| $21.33M | $16.08M | $20.36M | $13.63M | |
| $17.1M | $10.92M | $7.48M | $3.99M | |
| $38.43M | $27M | $27.85M | $17.62M | |
| $0 | $603.57K | $1.17M | $982.86K | |
| $1.41M | $1.16M | $862.97K | $431.8K | |
| -$152.52K | $1.26M | -$1.08M | -$1.37M | |
| -$38.59M | -$25.74M | -$28.93M | -$18.99M | |
| $19.09K | $1804 | $36.42K | $0 | |
| -$38.58M | -$25.5M | -$28.22M | -$18.49M | |
| -$29.51K | -$241.95K | -$745.21K | -$501.14K | |
| USD/shares | -$1.03 | -$0.76 | -$1.17 | -$0.96 |
| USD/shares | -$1.03 | -$0.76 | -$1.17 | -$0.96 |
| shares | 39.96M | 33.93M | 24.15M | 19.29M |
| shares | 39.96M | 33.93M | 24.15M | 19.29M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.